• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过基于构象搜索的 3D-QSAR 发现高亲和力大麻素受体配体。

Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis.

机构信息

Department of Drug Sciences, University of Catania, V.le A. Doria, 95125 Catania, Italy.

Department of Chemical Sciences, University of Catania, V.le A. Doria, 95125 Catania, Italy.

出版信息

Molecules. 2018 Aug 30;23(9):2183. doi: 10.3390/molecules23092183.

DOI:10.3390/molecules23092183
PMID:30200181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6225167/
Abstract

Two 3D quantitative structure⁻activity relationships (3D-QSAR) models for predicting Cannabinoid receptor 1 and 2 (CB₁ and CB₂) ligands have been produced by way of creating a practical tool for the drug-design and optimization of CB₁ and CB₂ ligands. A set of 312 molecules have been used to build the model for the CB₁ receptor, and a set of 187 molecules for the CB₂ receptor. All of the molecules were recovered from the literature among those possessing measured values, and Forge was used as software. The present model shows high and robust predictive potential, confirmed by the quality of the statistical analysis, and an adequate descriptive capability. A visual understanding of the hydrophobic, electrostatic, and shaping features highlighting the principal interactions for the CB₁ and CB₂ ligands was achieved with the construction of 3D maps. The predictive capabilities of the model were then used for a scaffold-hopping study of two selected compounds, with the generation of a library of new compounds with high affinity for the two receptors. Herein, we report two new 3D-QSAR models that comprehend a large number of chemically different CB₁ and CB₂ ligands and well account for the individual ligand affinities. These features will facilitate the recognition of new potent and selective molecules for CB₁ and CB₂ receptors.

摘要

已经建立了两个用于预测大麻素受体 1 和 2(CB₁和 CB₂)配体的三维定量构效关系(3D-QSAR)模型,这是为了设计和优化 CB₁和 CB₂配体的药物而创建的实用工具。使用了一组 312 个分子来为 CB₁受体建立模型,使用了一组 187 个分子来为 CB₂受体建立模型。所有分子均从文献中回收,其中包含已测量的 值,并且使用 Forge 作为软件。该模型显示出高且稳健的预测潜力,这得到了统计分析质量的证实,并且具有足够的描述能力。通过构建 3D 图谱,可以直观地理解突出 CB₁和 CB₂配体主要相互作用的疏水性、静电和形状特征。然后,使用该模型的预测能力对两种选定化合物进行了支架跳跃研究,生成了对两种受体具有高亲和力的新化合物库。在这里,我们报告了两个新的 3D-QSAR 模型,该模型包含了大量化学性质不同的 CB₁和 CB₂配体,并很好地解释了各个配体的亲和力。这些特征将有助于识别对 CB₁和 CB₂受体具有新的高效和选择性的分子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/0b888e2c13cb/molecules-23-02183-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/547599a8fd6a/molecules-23-02183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/c4ca9bd6e005/molecules-23-02183-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/9b2b2d74a8ad/molecules-23-02183-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/2ff3ce5409a0/molecules-23-02183-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/feb071dc0691/molecules-23-02183-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/a7b652b41dab/molecules-23-02183-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/817a2d5c104f/molecules-23-02183-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/a6a3c5f1dedf/molecules-23-02183-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/08e7171d2e72/molecules-23-02183-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/0b888e2c13cb/molecules-23-02183-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/547599a8fd6a/molecules-23-02183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/c4ca9bd6e005/molecules-23-02183-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/9b2b2d74a8ad/molecules-23-02183-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/2ff3ce5409a0/molecules-23-02183-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/feb071dc0691/molecules-23-02183-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/a7b652b41dab/molecules-23-02183-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/817a2d5c104f/molecules-23-02183-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/a6a3c5f1dedf/molecules-23-02183-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/08e7171d2e72/molecules-23-02183-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b905/6225167/0b888e2c13cb/molecules-23-02183-g010.jpg

相似文献

1
Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis.通过基于构象搜索的 3D-QSAR 发现高亲和力大麻素受体配体。
Molecules. 2018 Aug 30;23(9):2183. doi: 10.3390/molecules23092183.
2
7-Alkyl-3-benzylcoumarins: a versatile scaffold for the development of potent and selective cannabinoid receptor agonists and antagonists.7-烷基-3-苄基香豆素:一种用于开发有效和选择性大麻素受体激动剂和拮抗剂的多功能支架。
J Med Chem. 2012 Sep 27;55(18):7967-77. doi: 10.1021/jm3008213. Epub 2012 Sep 11.
3
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands.用于鉴定潜在强效和选择性σ-2受体配体的联用3D-QSAR统计模型-骨架跃迁分析
Eur J Med Chem. 2017 Oct 20;139:884-891. doi: 10.1016/j.ejmech.2017.08.053. Epub 2017 Aug 25.
4
3D-QSAR/CoMFA-based structure-affinity/selectivity relationships of aminoalkylindoles in the cannabinoid CB1 and CB2 receptors.基于3D-QSAR/CoMFA的大麻素CB1和CB2受体中氨基烷基吲哚的结构-亲和力/选择性关系
Molecules. 2014 Mar 5;19(3):2842-61. doi: 10.3390/molecules19032842.
5
The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2.3D-QSAR研究在烷基侧链C1'位置被取代的新型大麻素配体对与大麻素受体CB1和CB2结合的结构要求方面的应用。
J Med Chem. 2007 Jun 14;50(12):2875-85. doi: 10.1021/jm0610705. Epub 2007 May 24.
6
In-silico designing and characterization of binding modes of two novel inhibitors for CB1 receptor against obesity by classical 3D-QSAR approach.通过经典的3D-QSAR方法对两种新型CB1受体抑制剂抗肥胖的结合模式进行计算机辅助设计与表征。
J Mol Graph Model. 2019 Jun;89:199-214. doi: 10.1016/j.jmgm.2019.03.016. Epub 2019 Mar 17.
7
Combined CoMFA and CoMSIA 3D-QSAR study of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.对苯并咪唑和苯并噻吩衍生物与CB2大麻素受体具有选择性亲和力的联合CoMFA和CoMSIA 3D-QSAR研究。
Eur J Pharm Sci. 2017 Apr 1;101:1-10. doi: 10.1016/j.ejps.2017.01.037. Epub 2017 Jan 28.
8
The bioisosteric concept applied to cannabinoid ligands.将生物等排概念应用于大麻素配体。
Curr Med Chem. 2012;19(28):4794-815. doi: 10.2174/092986712803341575.
9
3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.大麻素受体亚型CB1和CB2的芳基吡唑拮抗剂的3D-QSAR研究。一种核磁共振和比较分子场分析相结合的方法。
J Med Chem. 2006 Jan 26;49(2):625-36. doi: 10.1021/jm050655g.
10
Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB and CB receptors.使用对接和分子动力学对大麻素类似物进行虚拟筛选以针对 CB1 和 CB2 受体。
Comput Biol Chem. 2021 Dec;95:107590. doi: 10.1016/j.compbiolchem.2021.107590. Epub 2021 Oct 12.

引用本文的文献

1
Xylazine as an emerging new psychoactive substance; focuses on both 5-HT and κ-opioid receptors' molecular interactions and isosteric replacement.赛拉嗪作为一种新兴的新型精神活性物质;聚焦于5-羟色胺和κ-阿片受体的分子相互作用及等排取代。
Arch Pharm (Weinheim). 2025 Mar;358(3):e2500041. doi: 10.1002/ardp.202500041.
2
Identification of Novel CB2 Ligands through Virtual Screening and In Vitro Evaluation.通过虚拟筛选和体外评估鉴定新型 CB2 配体。
J Chem Inf Model. 2023 Feb 13;63(3):1012-1027. doi: 10.1021/acs.jcim.2c01503. Epub 2023 Jan 24.
3
Machine learning field 3D-QSAR models for serotonin 2A receptor psychoactive substances identification.

本文引用的文献

1
Pharmacological evaluation of new constituents of "Spice": synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds.“香料”新成分的药理学评估:基于吲哚、吲唑、苯并咪唑和咔唑骨架的合成大麻素
Forensic Toxicol. 2018;36(2):385-403. doi: 10.1007/s11419-018-0415-z. Epub 2018 Apr 26.
2
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis.通过 3D-QSAR 与骨架跃迁分析相结合鉴定潜在有效的血红素加氧酶 1 抑制剂。
ChemMedChem. 2018 Jul 6;13(13):1336-1342. doi: 10.1002/cmdc.201800176. Epub 2018 May 29.
3
Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.
用于5-羟色胺2A受体精神活性物质识别的机器学习领域3D-QSAR模型。
RSC Adv. 2021 Apr 20;11(24):14587-14595. doi: 10.1039/d1ra01335a. eCollection 2021 Apr 15.
4
Artificial Intelligence Technologies for COVID-19 De Novo Drug Design.人工智能技术在新冠病毒从头设计药物中的应用。
Int J Mol Sci. 2022 Mar 17;23(6):3261. doi: 10.3390/ijms23063261.
5
From Far West to East: Joining the Molecular Architecture of Imidazole-like Ligands in HO-1 Complexes.从远西到东方:连接HO-1复合物中咪唑样配体的分子结构
Pharmaceuticals (Basel). 2021 Dec 10;14(12):1289. doi: 10.3390/ph14121289.
6
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent Antiproliferative Activity.新型基于乙酰胺的血红素加氧酶-1 抑制剂的发现及其具有强大的抗增殖活性。
J Med Chem. 2021 Sep 23;64(18):13373-13393. doi: 10.1021/acs.jmedchem.1c00633. Epub 2021 Sep 2.
7
The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity.《心理onauts的苯二氮䓬类药物;定量构效关系(QSAR)分析及其生物活性的对接预测》
Pharmaceuticals (Basel). 2021 Jul 26;14(8):720. doi: 10.3390/ph14080720.
8
Virtual Screening of Constituents for the Identification of Selective Ligands for Cannabinoid Receptor 2.虚拟筛选成分以鉴定大麻素受体 2 的选择性配体。
Int J Mol Sci. 2020 Jul 26;21(15):5308. doi: 10.3390/ijms21155308.
9
Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach.计算工具在 FABP4 配体发现中的应用:一种统计和分子建模方法。
Mar Drugs. 2019 Oct 31;17(11):624. doi: 10.3390/md17110624.
10
Structure-Based Approach for the Prediction of Mu-opioid Binding Affinity of Unclassified Designer Fentanyl-Like Molecules.基于结构的方法预测未分类的芬太尼类设计分子对μ-阿片受体的结合亲和力。
Int J Mol Sci. 2019 May 10;20(9):2311. doi: 10.3390/ijms20092311.
滥用合成大麻素 MMB-和 MDMB-FUBINACA、MN-18、NNEI、CUMYL-PICA 和 5-氟-CUMYL-PICA 的分子和行为药理学特征。
J Pharmacol Exp Ther. 2018 May;365(2):437-446. doi: 10.1124/jpet.117.246983. Epub 2018 Mar 16.
4
Synthetic marijuana is no more marijuana.合成大麻不再是大麻。
Asian J Psychiatr. 2019 Jun;43:211-212. doi: 10.1016/j.ajp.2017.11.002. Epub 2017 Nov 11.
5
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands.用于鉴定潜在强效和选择性σ-2受体配体的联用3D-QSAR统计模型-骨架跃迁分析
Eur J Med Chem. 2017 Oct 20;139:884-891. doi: 10.1016/j.ejmech.2017.08.053. Epub 2017 Aug 25.
6
Antidote to cannabinoid intoxication: the CB receptor inverse agonist, AM251, reverses hypothermic effects of the CB receptor agonist, CB-13, in mice.大麻素中毒解毒剂:CB 受体反向激动剂 AM251 逆转 CB 受体激动剂 CB-13 对小鼠的解热作用。
Br J Pharmacol. 2017 Nov;174(21):3790-3794. doi: 10.1111/bph.13973. Epub 2017 Sep 20.
7
3D-QSAR studies on Maslinic acid analogs for Anticancer activity against Breast Cancer cell line MCF-7.3D-QSAR 研究玛斯啉酸类似物对 MCF-7 乳腺癌细胞系的抗癌活性。
Sci Rep. 2017 Jul 20;7(1):6019. doi: 10.1038/s41598-017-06131-0.
8
Sigma-2 receptor ligands QSAR model dataset.西格玛-2受体配体定量构效关系(QSAR)模型数据集。
Data Brief. 2017 Jun 16;13:514-535. doi: 10.1016/j.dib.2017.06.022. eCollection 2017 Aug.
9
Crystal structures of agonist-bound human cannabinoid receptor CB.激动剂结合的人源大麻素受体CB的晶体结构
Nature. 2017 Jul 27;547(7664):468-471. doi: 10.1038/nature23272. Epub 2017 Jul 5.
10
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis.通过基于蒙特卡罗的定量构效关系分析开发西格玛-2 受体亲和滤器。
Eur J Pharm Sci. 2017 Aug 30;106:94-101. doi: 10.1016/j.ejps.2017.05.061. Epub 2017 May 29.